AGP Picks
View all

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on June 14, 2026

Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading
Stake Launches its Referral Code SHIMA – 200% Bonus and 5% Cashback for New Users in 2026
ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS
Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges POET Technologies Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges Lucid Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges Verra Mobility Corporation Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges Zillow Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Modat adds Passive DNS to its Platform Magnify, Connecting Every Signal in a Single Investigation Graph
Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting
Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)
Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting
ディファイアンスETFs、シーボーBZX取引所におけるディファイアンス・デイリー2XスペースETF (SPCL) の一時取引停止を発表
스페이스X 2배 레버리지 ETF (SPCL), Cboe BZX 거래소 조치로 거래 일시 중지했다고 Defiance ETFs가 발표
Defiance ETFs Umumkan Penggantungan Sementara Dagangan Defiance Daily 2X Space ETF (SPCL) di Cboe BZX Exchange, Inc.
Defiance ETFs 宣布 Defiance Daily 2X Space ETF (SPCL) 在 Cboe BZX Exchange, Inc. 暂停交易
Defiance ETFs 宣佈,Defiance Daily 2X Space ETF (SPCL) 暫時停止於 Cboe BZX Exchange, Inc. 進行交易

Share this page:

Sign up for:

Tech Times of New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.